Latest News of BIOS
Is Harmony Biosciences Holdings, Inc. (HRMY) the Best Cheap Growth Stock to Buy According to Analysts?
By Yahoo! Finance |
2 days ago
An article discusses the market response to the recent Federal Reserve rate cuts and insights from Tom Lee on market behavior pre-election. It also highlights Harmony Biosciences as a cheap growth sto...
Jim Cramer on Regeneron Pharmaceuticals Inc. (REGN): 'Leerink Analysts Downgraded Regeneron To A Market Perform Hold After A Negative Eylea 2mg Biosimilar Preliminary Injunction Ruling'
By Yahoo! Finance |
3 days ago
The article discusses Jim Cramer's investing experiences and emphasizes the importance of starting early in the stock market. It also highlights Regeneron Pharmaceuticals Inc. as a strong investment o...
Stocks To Watch: Harmony Biosciences Sees RS Rating Jump To 84
By Investor's Business Daily |
4 days ago
Learn how to find game-changing stocks by focusing on technical performance. Look for stocks with an RS Rating above 80. Harmony Biosciences shows potential but is currently outside a proper buy zone....
-
Is Avidity Biosciences Inc. (RNA) the Best Performing Small-Cap Stock in 2024?
By Yahoo! Finance | 4 days agoAvidity Biosciences Inc. (NASDAQ:RNA) ranks 1st among the best-performing small-cap stocks in 2024. The company is developing innovative RNA therapeutics targeting genetic defects, showing promising r...
-
Skye Bioscience Shares Gain After Highlighting Safety of In-Development Obesity Treatment
By MarketWatch | 1 week agoSkye Bioscience's shares surged 15% after emphasizing the safety of their obesity treatment compared to competitors. The company highlighted the absence of neuropsychiatric side effects in their trial...
-
Harmony Biosciences Holdings, Inc. (HRMY): Short Seller Sentiment is Bearish
By Yahoo! Finance | 1 week agoA review of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) against other 52-week high stocks is provided. With the US Federal Reserve cutting rates, a shift in the investment landscape is observed. ...
-
Institutional owners may take dramatic actions as Coherus BioSciences, Inc.'s (NASDAQ:CHRS) recent 12% drop adds to one-year losses
By Yahoo! Finance | 1 week agoAnalyzing analyst forecasts and ownership data can help predict a company's future performance. Institutional investors, holding 65% of Coherus BioSciences, greatly impact stock prices. With hedge fun...
-
Arcus Biosciences, Inc. (RCUS) Stock Price, News, Quote & History
By Yahoo! Finance | 1 week agoArcus Biosciences granted new employees options to purchase 27,800 shares of common stock at $16.31 per share. The company focuses on developing cancer treatments....
-
Twist Bioscience Clears Key Benchmark, Hitting 90-Plus RS Rating
By Investor's Business Daily | 2 weeks agoDiscover top growth stocks with IBD Screen of the Day, identifying market leaders based on price performance over the last 52 weeks. Key tips for stock investing include watching RS Rating, entry poin...
-
Director Kristiina Vuori Purchases Shares of Inhibrx Biosciences Inc (INBX)
By Yahoo! Finance | 2 weeks agoInhibrx Biosciences Inc (NASDAQ:INBX) is a biotech company developing therapeutic candidates for various medical needs. Recent insider transactions show more buying than selling, indicating confidence...
-
Twist Bioscience Joins Elite Club Of Stocks With RS Ratings Over 90
By Investor's Business Daily | 2 weeks agoLearn how to scale out of losing stocks using three signals, including the Relative Strength (RS) Rating. Stocks with an RS Rating of 80 or higher tend to perform well. IBD's RS Rating helps in identi...
-
Avid Bioservices Shares Gain Following Higher Revenue, Positive Outlook
By MarketWatch | 2 weeks agoAvid Bioservices saw a 19% increase in stock price after a strong fiscal first quarter with higher revenue. The company reported $40.2 million in revenue and $5.5 million net loss. It forecasts growth...
-
Stocks To Watch: Harmony Biosciences Sees RS Rating Rise To 84
By Investor's Business Daily | 3 weeks agoLearn how to trade options by choosing the right strategy for best results, using IBD's proprietary rating system to track market leadership. Discover the importance of RS rating in identifying top-pe...
-
Pacific Biosciences of California, Inc. (PACB): Among the Worst ARK Stocks According to Short Sellers
By Yahoo! Finance | 3 weeks agoThe article discusses Cathie Wood's ARK Investment strategy, focusing on disruptive innovation stocks. It highlights the performance of some top stocks and mentions Pacific Biosciences of California, ...
-
Twist Bioscience Corporation (TWST): Among the Worst ARK Stocks According to Short Sellers
By Yahoo! Finance | 3 weeks agoThis article discusses the performance of Twist Bioscience Corporation (NASDAQ:TWST) as an ARK stock and its potential in the gene editing industry. It also highlights Cathie Wood's investment strateg...